Buying the entire network, Cencora to acquire American Oncology Network for $2.4B
Landon Capital News
Cencora, Inc. (COR) has signed a definitive agreement to acquire American Oncology Network, Inc. (AONC), a physician-led network of more than 350 oncology providers across 21 states, according to a press release from the company.
The transaction values AON at an enterprise value of $2.4 billion, consisting of $2.3 billion at closing and contingent value rights of up to $100 million, payable upon the satisfaction of certain conditions. Cencora currently holds approximately 4% of AON’s equity and has agreed to acquire all remaining equity interests it does not currently own.
Certain AON stockholders may participate in an equity rollover representing up to 25% of AON. Assuming full participation in that rollover, Cencora expects to pay approximately $1.7 billion to increase its ownership stake to 75%.
Cencora expects the acquisition to be accretive to its adjusted diluted EPS in the second year following closing. The company also updated its fiscal year 2026 adjusted diluted EPS guidance to at least $17.90, at the high end of its previous range of $17.75 to $17.95.
About Landon Capital
Landon Capital Inc. is a media company that wholly owns subsidiaries Landon Capital Management LLC and Landon Capital News. Landon Capital News distributes economic, and political news in over 176 countries. Landon Capital News provides an in depth and simplistic look at financial, economic, and political news, as it is happening. We also provide our viewers with in-depth analysis on various companies and political news that directly correlate to economics. We bridge the gap of information between the investor and the markets, sectors and industries that they invest. For more information, please contact us at info@landoncapital.net or 404-995-6671 or visit https://landoncapital.net.
Safe Harbor Statement
This release does not constitute an offer to sell or a solicitation of offers to buy any securities of any entity. Landon Capital received no direct compensation related to this release. This release contains certain forward-looking statements based on current expectations, forecasts and assumptions that involve risks and uncertainties. Forward-looking statements in this release are based on information available to us as of the date hereof. Actual results may differ materially from those stated or implied in.
